These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 4976734)
1. Man behind a mask. An analysis of the psychomotor phenomena of Parkinson's disease. Lit AC Acta Neurol Psychiatr Belg; 1968; 68(12):863-74. PubMed ID: 4976734 [No Abstract] [Full Text] [Related]
2. [Etiology of Parkinson's syndrome and disease]. Honczarenko K; Kulcyzycki J Pol Tyg Lek; 1975 Jun; 30(25):1069-70. PubMed ID: 1135085 [No Abstract] [Full Text] [Related]
3. A double-blind evaluation of S.D. 25 in the treatment of Parkinson's disease. Strang RR Curr Med Drugs; 1966 Dec; 7(4):20-6. PubMed ID: 5976205 [No Abstract] [Full Text] [Related]
4. The etiology of Parkinson's disease. Strang RR Dis Nerv Syst; 1970 Jun; 31(6):381-90. PubMed ID: 5456765 [No Abstract] [Full Text] [Related]
5. Clinical evaluation of biperiden in Parkinson's disease. Strang RR Dis Nerv Syst; 1967 Mar; 28(3):191-3. PubMed ID: 5335879 [No Abstract] [Full Text] [Related]
9. Benign early-onset Parkinson's disease: a syndrome distinct from classic postencephalitic parkinsonism. Scott RM; Brody JA Neurology; 1970 Apr; 20(4):400. PubMed ID: 5535037 [No Abstract] [Full Text] [Related]
10. [Some psychodiagnostic aspects of Parkinson's syndrome with regard to different etiology and various degrees of severity]. Kirchner C Z Psychol Z Angew Psychol; 1970; 177(1):91-111. PubMed ID: 4396724 [No Abstract] [Full Text] [Related]
11. The Graeme Robertson memorial lecture, 1983. The long-term prognosis of Parkinson's disease. Selby G Clin Exp Neurol; 1984; 20():1-25. PubMed ID: 6391761 [TBL] [Abstract][Full Text] [Related]
12. [Psychic manifestations during treatment of Parkinson's disease with L-dopa]. Bonduelle M Rev Neurol (Paris); 1970 Feb; 122(2):140. PubMed ID: 5517897 [No Abstract] [Full Text] [Related]
13. Pergolide in the treatment of Parkinson's disease. Quinn NP; Lang AE; Thompson C; Brincat S; Marsden CD; Parkes JD Adv Neurol; 1984; 40():509-13. PubMed ID: 6695628 [No Abstract] [Full Text] [Related]
14. [Virologic and immunologic considerations in Parkinson's disease]. Irkeç C Mikrobiyol Bul; 1982; 16(4):293-6. PubMed ID: 6304477 [TBL] [Abstract][Full Text] [Related]
15. Anxiety and motor performance in Parkinson's disease. Siemers ER; Shekhar A; Quaid K; Dickson H Mov Disord; 1993 Oct; 8(4):501-6. PubMed ID: 8232361 [TBL] [Abstract][Full Text] [Related]
17. Is Parkinson's disease a homogeneous disorder--what is the burden of Parkinson's disease in India. Ghosh B; Mishra A; Sengupta P J Indian Med Assoc; 2005 Mar; 103(3):146, 148, 150 passim. PubMed ID: 16173291 [TBL] [Abstract][Full Text] [Related]
18. [Anatomic lesions in Parkinson's disease and parkinsonian syndromes]. Escourolle R Ann Med Interne (Paris); 1972 Apr; 123(4):349-56. PubMed ID: 5077039 [No Abstract] [Full Text] [Related]
19. [Evaluation of effectiveness of the micrographia's therapy in Parkinson's disease patients]. Jarzebska E Pol Merkur Lekarski; 2006 Jun; 20(120):688-90. PubMed ID: 17007269 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between weight loss and dysphagia in patients with Parkinson's disease]. Nozaki S; Saito T; Matsumura T; Miyai I; Kang J Rinsho Shinkeigaku; 1999 Oct; 39(10):1010-4. PubMed ID: 10655760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]